Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Niagen Bioscience Inc’s stock clocked out at $13.88, down -1.84% from its previous closing price of $14.14. In other words, the price has decreased by -$1.84 from its previous closing price. On the day, 0.71 million shares were traded.
Ratios:
To gain a deeper understanding of NAGE’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 56.07. For the most recent quarter (mrq), Quick Ratio is recorded 3.12 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on May 27, 2025, initiated with a Buy rating and assigned the stock a target price of $13.
B. Riley Securities Downgraded its Buy to Neutral on August 11, 2022, whereas the target price for the stock was revised from $6 to $2.40.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Lopez Carlos Luis bought 273 shares for $7.86 per share. The transaction valued at 2,146 led to the insider holds 2,251 shares of the business.
Jaksch Frank L Jr sold 37,161 shares of NAGE for $229,956 on Dec 13 ’24. The Director now owns 244,179 shares after completing the transaction at $6.19 per share. On Dec 13 ’24, another insider, Frank Jaksch Jr., who serves as the affiliate of the company, bought 37,161 shares for $6.19 each.
Valuation Measures:
As of this moment, Niagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 80.37, and their Forward P/E ratio for the next fiscal year is 57.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.13 while its Price-to-Book (P/B) ratio in mrq is 19.67.
Stock Price History:
Over the past 52 weeks, NAGE has reached a high of $14.49, while it has fallen to a 52-week low of $2.31. The 50-Day Moving Average of the stock is 46.18%, while the 200-Day Moving Average is calculated to be 112.57%.
Shares Statistics:
A total of 78.43M shares are outstanding, with a floating share count of 49.81M. Insiders hold about 36.77% of the company’s shares, while institutions hold 31.88% stake in the company.
